at Nasdaq.com (Thu, 3:11PM)
Xilinx (XLNX) warns its FQ2 sales will decline 7-10% Q/Q, compared with prior guidance for -3%...
Xilinx (XLNX) warns its FQ2 sales will decline 7-10% Q/Q, compared with prior guidance for -3% to +1% growth. Though this expected decline is worse than the one forecast by rival Altera (ALTR), investors only appear slightly bothered by it: Xilinx is down just 0.5% premarket.
How did this change your view of ?
More Bullish More Bearish It Didn't
This impact ()
Thanks for sharing your thoughts.
Submit & View Results
From other sites
at Investor's Business Daily (Thu, 1:42PM)
at Zacks.com (Thu, 8:15AM)
at Zacks.com (Jan 19, 2015)
at Zacks.com (Jan 16, 2015)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs